Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy
Clinical trial NCT00224068 · COMPLETED
Trial details
- NCT number
- NCT00224068
- Sponsor
- Watson Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2002-05-01
- Primary completion
- 2003-12-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.